Page 7 - Hong Kong Public News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Recbio Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange

/PRNewswire/ The China-based novel vaccines company - Jiangsu Recbio Technology Co., Ltd. ("Recbio" or the "Company", stock code: 2179.HK, today announced.

United statesNew zealandHong kongScientific rd teamInternational placingInternational capitalNovel adjuvant technologyStock exchangeEssence international securities hong kongGf securities hong kong brokerageDevelopment of next generation vaccine candidatesMorgan stanley asiaCapital marketsPorda havas international finance communications groupHaitong international securities companyDevelopment of novel vaccines

Recbio Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange

Recbio Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange - read this article along with other careers information, tips and advice on BioSpace

United statesNew zealandHong kongScientific rd teamInternational placingInternational capitalJiangsu recbio technology co ltdNovel adjuvant technologyStock exchangeEssence international securities hong kongGf securities hong kong brokerageDevelopment of next generation vaccine candidatesMorgan stanley asiaCapital marketsPorda havas international finance communications groupHaitong international securities company

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

Yang luHong kongEdward yongxiang wangPatricky luYun monica zhangGeorge jiSirnaomics ltdTherapeutics biopharmaceutical companyStock exchange of hong kong limitedInternational offeringSirnaomics or companyBiopharmaceutical companyMain boardStock exchangeHong kong limitedChina chief operating officer

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

Sirnaomics Ltd , the RNA Therapeutics Biopharmaceutical Company with Strong Presence in Both China and the U S Successfully Listed on Main Board of SEHK

HONG KONG, Dec 30, 2021 - (ACN Newswire) - Sirnaomics Ltd. ("Sirnaomics" or "Company", together with its subsidiaries, the "Group", stock code: 2257.HK), the RNA therapeutics biopharmaceutical company with strong presence in both China and the U.S., and the first company to achieve positive Phase IIa clinical outcomes in oncology for an RNAi therapeutics, is officially listed and commenced trading.

Yang luHong kongEdward yongxiang wangPatricky luYun monica zhangGeorge jiSirnaomics ltdStock exchange of hong kong limitedInternational offeringSirnaomics or companyMain boardStock exchangeHong kong limitedChina chief operating officerBoard secretaryJoint company secretary